Barbara Crosse

665 total citations
12 papers, 227 citations indexed

About

Barbara Crosse is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Barbara Crosse has authored 12 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Barbara Crosse's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Barbara Crosse is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Barbara Crosse collaborates with scholars based in United Kingdom, Ireland and United States. Barbara Crosse's co-authors include Joyce Thompson, D. Muthukumar, Gary Middleton, Kate Fife, Paul Taylor, Allan Hackshaw, Yenting Ngai, Susan Harden, Stephen Nash and Michael J. Seckl and has published in prestigious journals such as Journal of Clinical Oncology, Thorax and European Journal of Cancer.

In The Last Decade

Barbara Crosse

11 papers receiving 215 citations

Peers

Countries citing papers authored by Barbara Crosse

Since Specialization

Citations

This map shows the geographic impact of Barbara Crosse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Crosse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Crosse more than expected).

Fields of papers citing papers by Barbara Crosse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Crosse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Crosse. The network helps show where Barbara Crosse may publish in the future.

Co-authorship network of co-authors of Barbara Crosse

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Crosse. A scholar is included among the top collaborators of Barbara Crosse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Crosse. Barbara Crosse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial 2017 ·European Journal of Cancer ·David Ferry, Lucinda Billingham, Hugh Jarrett, David J. Dunlop, Penella J. Woll, M. Nicolson, Riyaz Shah, Joyce Thompson, James Spicer, D. Muthukumar, G. Skailes, Pauline Leonard, A.D. Chetiyawardana, Paula Wells, C. Lewanski, Barbara Crosse, (unknown), Piers Gaunt, Kenneth J. O’Byrne	15
2	Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR) 2017 ·Journal of Clinical Oncology ·Michael J. Seckl, Christian H. Ottensmeier, Michael Cullen, Peter Schmid, Yenting Ngai, D. Muthukumar, Joyce Thompson, Susan Harden, Gary Middleton, Kate Fife, Barbara Crosse, Paul Taylor, Stephen Nash, Allan Hackshaw	88
3	Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer 2015 ·Lung Cancer ·Rohit Lal, Gunnar Hillerdal, Riyaz Shah, Barbara Crosse, Joyce Thompson, M. Nicolson, Anders Vikström, Vanessa Potter, Carla Visseren‐Grul, María Gabriela Lorenzo, Yulia Dyachkova, Nawel Bourayou, Yvonne Summers	21
4	A multicenter phase III randomized double-blind placebo controlled trial of pravastatin added to first-line standard chemotherapy in patients with small cell lung cancer (SCLC). 2013 ·Journal of Clinical Oncology ·Michael J. Seckl, Christian H. Ottensmeier, Michael Cullen, Peter Schmid, Lindsay E. James, (unknown), (unknown), D. Muthukumar, Joyce Thompson, Susan Harden, Gary Middleton, Kate Fife, Barbara Crosse, Paul Taylor, Iftekhar Khan	2
5	S85 British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine combined with cisplatin 50 mg/m2 (GC50) vs cisplatin 80 mg/m2 (GC80) vs carboplatin AUC 6 (GCb6) in advanced NSCLC 2011 ·Thorax ·D. Ferry, Lucinda Billingham, Hugh Jarrett, David J. Dunlop, Joyce Thompson, Mohan Kumar, G. Skailes, M. Nicolson, Riddhishkumar Shah, Pauline Leonard, (unknown), Paula Wells, C. Lewanski, Penella J. Woll, Barbara Crosse, (unknown), Sarah Pirrie, Kenneth J. O’Byrne	8
6	S86 Quality of life in advanced non-small cell lung cancer, effects of cisplatin dose and carboplatin in combination with gemcitabine: results from BTOG2, a British Thoracic Oncology Group phase III trial in 1363 patients 2011 ·Thorax ·Lucinda Billingham, Piers Gaunt, Hugh Jarrett, David J. Dunlop, Joyce Thompson, Kenneth J. O’Byrne, Mohan Kumar, G. Skailes, M. Nicolson, Riyaz Shah, Pauline Leonard, (unknown), Paula Wells, C. Lewanski, Penella J. Woll, Barbara Crosse, (unknown), D. Ferry	4
7	S87 Delivered dose intensity of gemcitabine 1250 mg/m2 with cisplatin at 80 mg/m2 (GC80) and 50 mg/m2 (GC50) and carboplatin AUC 6 (GCb6) in a phase III trial of advanced non-small cell lung cancer (NSCLC): correlations with clinical outcomes 2011 ·Thorax ·David J. Dunlop, D. Ferry, Hugh Jarrett, Lucinda Billingham, Joyce Thompson, Mohan Kumar, G. Skailes, M. Nicolson, Rakesh Shah, Pauline Leonard, (unknown), Paula Wells, C. Lewanski, Penella J. Woll, Barbara Crosse, Kenneth J. O’Byrne	0
8	Computed Tomography Findings of Gaseous Necrosis in Epithelial Ovarian Cancer: A Report of Three Cases 2002 ·Journal of Computer Assisted Tomography ·Paul Cronin, Barbara Crosse, Geoff Lane, John Spencer	1
9	Gastroduodenal Obstruction from Ovarian Cancer: Imaging Features and Clinical Outcome 2000 ·Clinical Radiology ·John Spencer, Barbara Crosse, (unknown), (unknown), Timothy Perren, (unknown)	11
10	Ovine psittacosis and sarcoidosis in a pregnant woman. 1991 ·Thorax ·Barbara Crosse, (unknown), (unknown)	16
11	Psittacosis: A clinical review 1990 ·Journal of Infection ·Barbara Crosse	55
12	Hepatitis B markers in West Yorkshire firemen 1989 ·Epidemiology and Infection ·Barbara Crosse, C. Teale, Emma Lees	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact